PharmaZee prices five tracked peptides with the introductory rate and the ongoing rate printed side by side, names both filling pharmacies, and carries a federal warning letter naming its own domain.
What PharmaZee charges
Sermorelin: $199/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $140.00
NAD+: $175/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $110.00
NAD+: $185/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $120.00
Glutathione: $149/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $99.00
PT-141: $175/mo — recurring monthly on the 1-Month Supply tab; the same panel prints a first month of $110.00
PharmaZee is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
The introductory rate is not hidden
Each product panel prints the first-month figure and the recurring figure together rather than leading with the cheaper one alone.
That is the opposite of the shape a buyer has to watch for, where an introductory rate is advertised and the ongoing rate is discovered after the first renewal.
Every figure recorded here comes from the panel the page opens on, which is the single-month option.
A three-month option exists on all five products and was deliberately not opened, so nothing here is a quarterly total or a division of one.
Five products, four compounds, two routes of one of them
This seller prices five products covering four of the compounds this site tracks.
Two of the five are different routes of the same compound, each with its own concentration and container size stated.
There is no sitemap on this host, so the product list had to be taken from the seller's own navigation.
The nonsense-path control on the same host renders a fraction of the length of any real product page and returns a not-found code.
Everything checkable is behind a click
Asked which pharmacies fill its prescriptions, the seller names two, each with a street address and opening hours.
That answer is inside a collapsed accordion, and every product page says only that medication comes direct from a licensed pharmacy.
The coverage answer is collapsed in the same way, and it is not the answer its heading suggests.
Anything read only from the open page would have recorded this seller as naming no pharmacy and stating no coverage.
Named prescribers are not a service area
The coverage answer says the seller operates in the United States only, with restrictions that vary by therapy and medication.
It then names individual physicians assigned to patients in four particular states.
A prescriber's licence is that person's fact, not the company's footprint, and it is not read as a coverage claim here.
No state list is published anywhere, and no claim about lab work appears at all.
Who it's for
Readers who want the introductory rate and the ongoing rate on the same screen.
Buyers comparing several tracked compounds at one seller.
Shoppers who want the concentration and container size stated on the product.
Anyone choosing between an injectable and a nasal route for the same compound.
Who should look elsewhere
Readers who will not buy from a seller with a federal warning letter naming its domain.
Buyers who need a published state list before ordering.
Shoppers who will not click through accordions to find who fills the prescription.
Anyone who expects lab work to be part of what they pay.
Strengths
Prints the first-month figure and the recurring figure together, so the introductory rate is not disguised
Prices five products covering four tracked compounds, including two routes of the same one
Names both filling pharmacies with street addresses in its FAQ
States the concentration and bottle size on the products where those differ
Trade-offs
Carries a federal warning letter that names this exact domain
Hides the pharmacy names and the coverage answer inside collapsed accordions
Publishes no state list and answers the coverage question with named prescribers instead
Serves no sitemap, so the product list can only be found through the navigation
FDA disclosure
PharmaZee received an FDA warning letter issued February 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
How we verified this
Read every page cited on this row as rendered text in a real browser, not as served HTML, because several sellers in this pass ship the figure in by script and serve a bare currency sign.
Fired a nonsense-path control at this host in the same run and judged it on the rendered document rather than on its status code or its byte count.
Joined every text node before scanning for a currency sign, so a figure split across nested elements could not read as an absence.
Clicked every collapsed accordion on the pages read, because pharmacy names, state answers and lab conditions hid inside them on most sellers checked this pass.
Read each figure inside its own card or panel rather than by nearness to a compound name, on pages that price weight-loss lines beside peptide lines.
Recorded the seller's own published figure and never divided a multi-month total into a monthly one.
Screened this seller in the live federal warning-letter record by entity and by brand, with a known-good positive control and a nonsense negative control fired in the same run.
Read the company column of every returned record rather than accepting a full-text match, and attached no letter unless the letter itself named this seller's own domain.
Opened the single-month panel only, and left the three-month option closed, so no figure here is a multi-month total or a division of one.
Opened the pharmacy answer and the coverage answer individually rather than clicking every control at once, which closes as many as it opens.
Treated the physicians named in the coverage answer as prescribers rather than as evidence of a company service area.
A provider to compare PharmaZee against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.